Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Making Science Count for Patients: CDK4/6

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
CDK 4/6 inhibitors: Preclinical, approval, and optimization
Richard S Finn
UCLA, Los Angeles, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
CDK 46/inhibitors: Beyond efficacy speaker
Ben O'Leary
Royal Marsden Hospital Inst. of Cancer Res., London, United Kingdom
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
CDK 4/6 inhibitors: Evolving data outside of breast cancer
Jessica Teh
Thomas Jefferson Univ., Philadelphia, PA, United States
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3